Gyre Therapeutics (GYRE) Net Margin Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3,082.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,120.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -653.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,849.00 |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | -5,083.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,083.00 |
| Dec 31, 2025 | -428.00 |
| Sep 30, 2025 | 740.00 |
| Jun 30, 2025 | -1,234.00 |
| Mar 31, 2025 | -1,549.00 |
| Dec 31, 2024 | 37,170.00 |
| Sep 30, 2024 | -800.00 |
| Jun 30, 2024 | 767.00 |
| Mar 31, 2024 | 1,872.00 |
| Dec 31, 2023 | -34,259.00 |
| Mar 31, 2023 | 183,973.00 |
| Dec 31, 2022 | 80,287.00 |
| Mar 31, 2022 | -30,121.00 |
| Dec 31, 2021 | 9,858.00 |
| Sep 30, 2021 | 69,763.00 |
| Jun 30, 2021 | -72,013.00 |
| Mar 31, 2021 | -150,475.00 |
| Mar 31, 2018 | -8.25 Mn |
| Dec 31, 2017 | 347,257.00 |
| Sep 30, 2017 | 255,537.00 |
| Jun 30, 2017 | -442,011.00 |
| Mar 31, 2017 | 176,848.00 |
| Dec 31, 2016 | 68,803.00 |
| Sep 30, 2016 | -106,330.00 |
| Jun 30, 2016 | -392,917.00 |
| Mar 31, 2016 | -229,065.00 |
| Dec 31, 2015 | -529,175.00 |
| Sep 30, 2015 | -242,528.00 |
| Jun 30, 2015 | 223,462.00 |
| Mar 31, 2015 | 404,541.00 |
| Dec 31, 2014 | 1.37 Mn |
| Mar 31, 2014 | -482,206.00 |
| Dec 31, 2013 | -1.16 Mn |
| Mar 31, 2013 | -23,799.00 |
| Dec 31, 2012 | -266,452.00 |
| Sep 30, 2012 | -97,815.00 |
| Jun 30, 2012 | 5,395.00 |
| Mar 31, 2012 | -2,240.00 |
| Dec 31, 2011 | -4,189.00 |
| Sep 30, 2011 | -187,571.00 |
| Jun 30, 2011 | -192,098.00 |